SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein binds to the cell receptor ACE2 allowing viral entry and infection. It is a 223 amino acid glycoprotein representing residues 319-541 of the spike protein S1 sequence. RBD from Molecular Innovations is useful for capturing SARS-CoV-2 specific antibodies from human plasma and serum in COVID-19 serological assays. Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 6X-Histidine tag at C terminus for purification.
Produced under license from the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Purity:>95% by SDS-PAGE analysis
Source:Human Embryonic Kidney cells
Molecular Weight:25,900
Extinction Coefficient:1.231
Storage:-70 C
Shipping Conditions:Dry ice
Expiration:3 years from delivery
Form :Frozen liquid
Buffer:PBS
Sample Size:0.05 mg
Sample Concentration :0.25 mg/ml
Sample Volume :0.2 ml
Gene Name:S1
Gene ID:43740568
UniProt ID:P0DTC2